Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from HUGroup Holdings ( (JP:4544) ).
H.U. Group Holdings reported a 1.8% rise in net sales to ¥247.4 billion for the year to March 31, 2026, with operating profit surging 81.0% to ¥4.8 billion and profit attributable to owners of parent climbing 147.1% to ¥6.8 billion, despite a sharp drop in ordinary profit due largely to weaker contributions from equity‑method affiliates. The company’s financial position remained solid, with an equity ratio of 51.3% and cash and cash equivalents of ¥48.1 billion, while it maintained an annual dividend of ¥125 per share and forecast higher sales and operating profit for fiscal 2027, signaling steady core business momentum but expecting lower bottom‑line profit as one‑off factors fade.
Operating cash flow stayed robust at ¥21.6 billion and investing cash flow turned positive on reduced outlays, though financing cash flow was negative amid higher dividend payments and treasury share purchases, resulting in a net increase in cash. Looking ahead to the year ending March 2027, management projects net sales of ¥256.0 billion and operating profit of ¥9.0 billion, nearly doubling operating earnings, but guides profit attributable to owners of parent down 26.7% to ¥5.0 billion, implying margin pressure or absence of extraordinary gains even as it continues its stable dividend policy.
The most recent analyst rating on (JP:4544) stock is a Buy with a Yen4370.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.
More about HUGroup Holdings
H.U. Group Holdings, Inc. is a Japan-based healthcare company listed on the Tokyo Stock Exchange that operates mainly in clinical testing and related diagnostic services. The group provides laboratory testing, in vitro diagnostics and other healthcare support solutions, serving medical institutions and contributing to the country’s medical infrastructure and public health systems.
Average Trading Volume: 257,214
Technical Sentiment Signal: Buy
Current Market Cap: Yen176.6B
For detailed information about 4544 stock, go to TipRanks’ Stock Analysis page.

